Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,763,919
-
Share change
-
-312,113
-
Total reported value
-
$94,242,278
-
Price per share
-
$4.14
-
Number of holders
-
31
-
Value change
-
-$1,079,987
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q2 2022
As of 30 Jun 2022,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,763,919 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., COMMODORE CAPITAL LP, NEA Management Company, LLC, SAMLYN CAPITAL, LLC, TPG GP A, LLC, Vivo Capital, LLC, AMERIPRISE FINANCIAL INC, Ikarian Capital, LLC, VANGUARD GROUP INC, and MORGAN STANLEY.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.